NF-kappaB-dependent lymphoid enhancer co-option promotes renal carcinoma metastasis
NF-kappaB-dependent lymphoid enhancer co-option promotes renal carcinoma metastasis
复制标题
DOI:
--
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Paulo Rodrigues;Saroor A. A. Patel-Saroor-A.-A.-Patel-10127182;L. Harewood;Ioana Olan;E. Vojtasova;S. Syafruddin;M. N. Zaini;E. Richardson;Johanna Burge;A. Warren;G. Stewart;K. Saeb‐Parsy;S. Samarajiwa;Sakari Vanharanta
中科院分区:
文献类型:
--
作者:
Paulo Rodrigues;Saroor A. A. Patel-Saroor-A.-A.-Patel-10127182;L. Harewood;Ioana Olan;E. Vojtasova;S. Syafruddin;M. N. Zaini;E. Richardson;Johanna Burge;A. Warren;G. Stewart;K. Saeb‐Parsy;S. Samarajiwa;Sakari Vanharanta
1) MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Biomedical Campus, Cambridge, CB2 0XZ, United Kingdom. 2) Cancer Research UK/Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, United Kingdom. 3) UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Jalan Yaa'cob Latiff, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. 4) Academic Urology Group, Department of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. 5) Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 6) Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.